Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
HIV-1 envelope determinants for cell tropism and chemokine receptor use.
Mol Membr Biol. 1999 Jan-Mar;16(1):57-65. Unique Identifier : AIDSLINE MED/99265142 Hoffman TL; Doms RW; Department of Pathology, University of Pennsylvania, Philadelphia; 19104, USA.
Abstract:
Isolates of human immunodeficiency virus type-1 (HIV-1) display marked differences in their ability to replicate in macrophages and transformed T-cell lines in vitro, a property that has important implications for disease pathogenesis. The restriction in replication between these two CD4-positive cell types is largely at the level of viral entry and is regulated by the viral envelope (env) gene. The envelope protein (Env) is responsible for fusion of the viral and host membranes, and a particular region of Env called the V3-loop has been implicated in regulating viral tropism. However, other regions of Env, such as the V1- and V2-loops, have been shown to modulate the effects of the V3-loop. The discovery that Env initially binds the CD4 molecule on the target cell surface and then makes subsequent interactions with one of several members of the chemokine receptor family has greatly enhanced the molecular understanding of HIV-1 entry. The differential use of chemokine receptors by different viral isolates and their expression in different cell types largely explains viral tropism. The same regions in Env responsible for virus tropism have also been shown to play an important role in mediating chemokine receptor use. The recent crystallization of HIV-1 Env in complex with CD4 illuminates the architecture of the components involved in mediating fusion between the viral and host membranes. The spatial relationship between variable structures of Env previously implicated in tropism and chemokine receptor use and conserved Env structures potentially involved in chemokine receptor binding are discussed.
Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Binding Sites Human HIV/*PATHOGENICITY HIV Envelope Protein gp120/CHEMISTRY/*PHYSIOLOGY Macrophages/VIROLOGY Models, Biological Models, Molecular Receptors, Chemokine/*PHYSIOLOGY Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. *Tropism 991030
A99A0934
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.
